The last good year for the word exosome
In one breath. If you read American beauty media this autumn, exosomes are the future. From Osaka the same sentences read like 2023, because Korea put the word on its prohibited list for cosmetic ads in January 2025, Europe never allowed the human-derived kind at all, and in June 2026 the first US class action over an exosome serum was filed. None of that says exosomes do nothing. It says the word on the box is a date, not a mechanism, and there are three better questions to ask.
Every section carries an evidence label: 観測 (observation), 研究知見 (research), 規制 (regulation), 公的記録 (public filing), 私の読み (my read). When I show you a claim, you will know what kind of claim it is. This is piece 1 of a series, "What the US is about to learn".
Where I am standing · 観測 observation
The serums are new, the price points are high, and the language is confident: regenerative, cell-signalling, the next retinol. I spent the first two days of October in a trade hall in Osaka where roughly every third booth sold an exosome or culture-medium ingredient, and almost every one of them had the same problem. Not the biology. The word.
What the word means · 研究知見 research
An exosome is a vesicle, roughly 30 to 150 nanometres across, that a cell releases carrying proteins, lipids and RNA. Cells use them to talk to each other. That part is real and interesting, and it is why my field spent a decade arguing about how to count them. The field's own consensus document, MISEV2023, asks anyone using the word to show size, number, surface markers and purity first. A preparation that has not been characterised that way is, strictly, "extracellular vesicle-like material", not exosomes. Very few cosmetic preparations clear that bar in public.
Three dates · 規制・公的記録 regulation, public filing
January 21, 2025. Korea's Ministry of Food and Drug Safety revised its cosmetic labelling and advertising guideline and added "exosome" to the prohibited expressions, under the heading of claims about human-derived ingredients. Korea is the country that made exosome skincare a category, and it did not ban the material. It restricted the claim implied by the name: a brand can still say the word only when the source is clearly not human, and many simply found other words. The serums stayed on the shelf.
The European Union, from the start. EU cosmetic regulation keeps a list of substances that cannot go into a cosmetic at all. Entry 416 of Annex II is cells, tissues and products of human origin. Most human-derived exosome ingredients, including conditioned media from human stem cells, cannot be sold in a European cosmetic however good the data is. Most of Southeast Asia and China draw the same line. Vesicles from plants, milk or microbes are a different story, which is why the sharpest ingredient makers I met this month were the ones who could say "plant-derived" in their first sentence.
June 16, 2026. A class action was filed in the United States alleging that a mass-market exosome serum's claims were not supported by the evidence behind them, among them that its plant-derived exosomes "help boost collagen production by 300%" and deliver "skin rejuvenation in 14 days, clinically proven". Those are allegations, not findings, and the case will take years. But the filing is the moment the US market joined a conversation Korea and Europe were already having. The FDA, separately, has been warning about exosome products marketed to clinics since 2019.
So "America is behind" is the wrong sentence · 私の読み my read
It is not that American skin is different or that American chemists are slower. It is that marketing runs ahead of regulation everywhere, and the US is simply earlier on a curve two other markets have already walked. Korea's honeymoon with the word ended in 2025. Europe never had one. The United States is in its last good year.
What does that mean when you are standing in front of the shelf? It means the word on the box is a date, not a mechanism. It tells you which year the marketing is in. It does not tell you whether the vesicles in the jar are still intact after formulation and six months on a shelf. It does not tell you whether they cross a healthy stratum corneum, which most things above about 500 daltons do not. And it does not tell you what was measured on human skin, how many people, for how long, against what. Those three gaps are where every exosome claim I have read this year either holds or falls.
Three questions instead of one word · 私の読み my read
- What is it derived from? Human, plant, milk, microbe. The answer decides which countries it can legally be sold in, and tells you how carefully the company has thought about everything else.
- How was it counted, and by whom? Size, number, markers, purity. A particle number without a method is just a number.
- What was tested on human skin? How many people, for how long, against what. If the answer is a fibroblast assay, the honest claim is about fibroblasts in a dish, and a good company will say so.
None of this says exosomes do nothing. Some of the biology is beautiful, and some of the plant-derived work is going to matter. It says the word has had its run, and the products that survive the next two years will be the ones that stopped leaning on it and started showing the measurement.
The word on the box is a date, not a mechanism. Ask for the measurement.
Keep reading
- What I check when I read a skincare claim, the method behind every post here.
- Calecim, read like a paper, a stem cell culture medium cream and the trial that could not tell it from the vehicle.
- Dr. Melaxin: 500 kDa is not 500 Da, on why size decides what a serum can do.
Sources. Korea MFDS, revised Guidelines on Cosmetic Labels and Advertisements, announced January 21, 2025, adding expressions about human-derived ingredients, exosome among them, to the prohibited list (as reported by ChemLinked, January 22, 2025). Regulation (EC) No 1223/2009, Annex II, entry 416: cells, tissues or products of human origin. Selby et al. v. Brand Evangelists for Beauty Inc., class action filed June 16, 2026, concerning The Inkey List Exosome Hydro-Glow Complex (allegations, not findings; complaint via classaction.org). US FDA, Public Safety Notification on Exosome Products, December 2019, and subsequent warning letters. Welsh JA et al., Minimal information for studies of extracellular vesicles (MISEV2023), J Extracell Vesicles 2024;13(2):e12404. Bos JD, Meinardi MM, The 500 Dalton rule for the skin penetration of chemical compounds and drugs, Exp Dermatol 2000;9:165-169. I review the scientific basis of English skincare claims for a living; nothing here refers to any client. Education, not medical advice.
